Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
NEULANDLAB

Neuland Laboratories Share Price

 

 

Neuland Laboratories live price: ₹16327. It opened at ₹16,590 vs previous close ₹16,590; intraday high/low: ₹16,747/₹16,260. The 50 & 200 DMA stand at ₹14,921.99/₹14,270.81.

Neuland Laboratories Performance

  • Today's Low
  • ₹16,260
  • Today's High
  • ₹16,747
  • 52 Week Low
  • ₹11,011
  • 52 Week High
  • ₹19,747
  • Open Price₹16,590
  • Previous Close₹16,590
  • Volume38,167
  • 50 DMA₹14,921.99
  • 100 DMA₹14,549.72
  • 200 DMA₹14,270.81

Neuland Laboratories Chart

Investment Returns

  • Over 1 Month + 6.75%
  • Over 3 Month + 19.88%
  • Over 6 Month -5.35%
  • Over 1 Year + 47.68%

Smart Investing Starts Here Start SIP with Neuland Laboratories for Steady Growth!

Invest Now

Neuland Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 57.5
  • PEG Ratio
  • 1.4
  • Market Cap Cr
  • 20,947
  • P/B Ratio
  • 12.6
  • Average True Range
  • 735.41
  • EPS
  • 283.71
  • Dividend Yield
  • 0.1
  • MACD Signal
  • 810.4
  • RSI
  • 58.06
  • MFI
  • 45.21

Neuland Laboratories Financials

Neuland Laboratories Technicals

EMA & SMA

Current Price
₹16,327.00
-263 (-1.59%)
pointer
  • Bearish Moving Average 5
  • Bullish Moving Average 11
  • 20 Day
  • ₹15,980.23
  • 50 Day
  • ₹14,921.99
  • 100 Day
  • ₹14,549.72
  • 200 Day
  • ₹14,270.81

Resistance and Support

16444.67 Pivot Speed
  • R3 17,116.33
  • R2 16,931.67
  • R1 16,629.33
  • S1 16,142.33
  • S2 15,957.67
  • S3 15,655.33

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Neuland Laboratories is a leading pharmaceutical company specializing in the manufacturing of active pharmaceutical ingredients (APIs) and custom manufacturing solutions. It serves global pharmaceutical companies with high-quality APIs for critical therapeutic areas, including cardiovascular and central nervous system.

Neuland Laboratories has an operating revenue of Rs. 2,022.99 Cr. on a trailing 12-month basis. An annual revenue growth of 37% is outstanding, Pre-tax margin of 24% is great, ROE of 19% is exceptional. The company has a reasonable debt to equity of 9%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 17% and 12% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 9% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 86 which is a GOOD score indicating consistency in earnings, a RS Rating of 87 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 59 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock has great fundamentals and technical strength to stay in momentum.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Neuland Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-12 Audited Results & Final Dividend
2026-02-09 Quarterly Results
2025-11-07 Quarterly Results
2025-07-31 Quarterly Results
2025-05-15 Audited Results & Final Dividend
Date Purpose Remarks
2025-07-18 FINAL Rs.12.00 per share(120%)Final Dividend
2022-07-15 FINAL Rs.5.00 per share(50%)Final Dividend
View Neuland Laboratories Dividend History Arrow

Neuland Laboratories Shareholding Pattern

32.63%
11.35%
1.3%
20.46%
0%
23.85%
10.41%

Neuland Laboratories FAQs

Neuland Laboratories share price is ₹16,327 As on 19 May, 2026 | 07:28

The Market Cap of Neuland Laboratories is ₹20947.4 Cr As on 19 May, 2026 | 07:28

The P/E ratio of Neuland Laboratories is 57.5 As on 19 May, 2026 | 07:28

The PB ratio of Neuland Laboratories is 12.6 As on 19 May, 2026 | 07:28

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23